trending Market Intelligence /marketintelligence/en/news-insights/trending/0Usus5WOHoQch1y3SuPYGw2 content esgSubNav
In This List

NovaBay regains NYSE American compliance

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


NovaBay regains NYSE American compliance

NovaBay Pharmaceuticals Inc. received notice from the NYSE American LLC that it has regained compliance with the exchange's continued listing standards.

The company previously received two noncompliance notices relating to stockholders' equity upon reports of losses from continuing operations or net losses for the most recent fiscal years.

The company said NYSE American will examine the company's method of financial recovery if it fails to meet any of the exchange's continued listing standards within 12 months of Dec. 7. NYSE American can also deem NovaBay to be out of compliance if its market cap falls below $50 million on a 30-trading-day average.